Detalles de la búsqueda
1.
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
Diabetes Obes Metab
; 24(4): 662-674, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34908223
2.
Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.
Diabetes Obes Metab
; 20(9): 2190-2199, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29766633
3.
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study.
J Diabetes Investig
; 14(3): 417-428, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716212
4.
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study.
Expert Opin Drug Saf
; 21(10): 1315-1328, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315729
5.
Healthcare resource utilization in patients treated with empagliflozin in East Asia.
J Diabetes Investig
; 13(5): 810-821, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859609
6.
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation.
Nat Rev Nephrol
; 17(1): 65-77, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33005037
7.
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.
BMJ Open
; 11(4): e045844, 2021 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827843
8.
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study.
Endocrinol Diabetes Metab
; 4(1): e00183, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33532619
9.
Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database.
Clin Epidemiol
; 12: 367-375, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32308492
10.
Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials.
Expert Opin Drug Saf
; 19(9): 1193-1202, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32552153
11.
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study.
Expert Opin Drug Saf
; 19(2): 211-221, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769309
12.
Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study.
Diabetes Ther
; 10(3): 951-963, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30912033
13.
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trials.
J Diabetes Investig
; 10(2): 418-428, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30099847
14.
Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial.
Clin Ther
; 41(10): 2021-2040.e11, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31561882
15.
URB is abundantly expressed in adipose tissue and dysregulated in obesity.
Biochem Biophys Res Commun
; 367(2): 370-6, 2008 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-18178152
16.
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes.
Diabetes Ther
; 9(2): 863-871, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29488164
17.
Foxo1 represses expression of musclin, a skeletal muscle-derived secretory factor.
Biochem Biophys Res Commun
; 364(2): 358-65, 2007 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17950246
18.
Enhancement of ligand-dependent vitamin D receptor transactivation by the cardiotonic steroid bufalin.
Biochem Pharmacol
; 70(10): 1479-86, 2005 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16183038
19.
Competitive binding of musclin to natriuretic peptide receptor 3 with atrial natriuretic peptide.
J Endocrinol
; 201(2): 287-95, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19244276
20.
Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.
Am J Physiol Endocrinol Metab
; 294(4): E778-84, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18198351